You are viewing the "Scott Hensley | NPR" Archives
An FDA committee votes to roll out a new COVID vaccination strategy
By: Scott Hensley | NPR
Posted on:
WASHINGTON (NPR) — A committee of advisers to the Food and Drug Administration voted unanimously on a proposal to simplify the nation’s strategy for vaccinating people against COVID-19. The recommendation… Read More
Advisers to the FDA back COVID vaccines for the youngest children
By: Scott Hensley | NPR
Posted on:
WASHINGTON, D.C. (NPR) — A committee of advisers to the Food and Drug Administration voted unanimously to recommend that the agency authorize COVID-19 vaccines from Moderna and Pfizer-BioNTech for children… Read More
The FDA postpones a highly anticipated meeting on the Pfizer vaccine for young kids
By: Scott Hensley | NPR
Posted on:
WASHINGTON, D.C. (NPR) — A highly anticipated meeting of expert advisers to discuss whether to recommend the use of the Pfizer-BioNTech COVID-19 vaccine for young children has been postponed. The… Read More
FDA authorizes 1st antiviral pill for COVID
By: Scott Hensley | NPR
Posted on:
WASHINGTON, D.C. (NPR) — In a highly anticipated decision, the Food and Drug Administration authorized the first antiviral pill to treat COVID-19 at home. The pill, called Paxlovid, is made… Read More
CDC advisers back expansion of COVID boosters for all adults
By: Scott Hensley | NPR
Posted on:
WASHINGTON, D.C. (NPR) — A panel of experts advising the Centers for Disease Control and Prevention unanimously backed the expansion of Moderna and Pfizer-BioNTech COVID-19 vaccine boosters to all adults…. Read More
Experts Advise FDA To Authorize Pfizer COVID Booster For People 65 And Older
By: Scott Hensley | NPR
Posted on:
WASHINGTON, D.C. (NPR) — In a surprising vote, a panel of advisers to the Food and Drug Administration recommended against approval of a booster dose of the Pfizer-BioNTech COVID-19 vaccine… Read More